Amplio Spine Acquires and Commercializes KeyLift®, an FDA-Cleared Expandable Interlaminar Stabilization System Indicated for Supplemental Fusion of the Non-Cerv... (opens in new tab)
Founder-led Amplio Spine, LLC enters national commercialization following its asset acquisition of KeyLift® from FloSpine, LLC — an FDA-cleared expandable interlaminar device whose Indications for Use specify plate fixation/attachment to the spinous processes/lamina. BOCA RATON, Fla., June 18, 2026 /PRNewswire/ — Amplio Spine today announced the close of its asset acquisition of the KeyLift® Expandable Interlaminar Stabilization System (FDA 510(k) K232484) […]
Read the original article